Loading
Loading
Advanced / Specialty Compounds Β· 5mg
Choose dose
Janoshik-tested Β· 10 vials per kit
PNC-27 is a synthetic chimeric peptide containing an MDM-2-binding domain and a transmembrane-penetrating sequence, studied in preclinical research for its selective anticancer properties. Research has examined its potential to bind HDM-2 expressed on cancer cell membranes, induce selective membranolysis of tumour cells while sparing normal cells, and trigger necrosis without apoptosis in various cancer cell lines.
β₯98%
Purity
Lyophilised
Format
2β3 wks
Arrival
Don't want to wait 3 weeks?
Check local stock β weekday same/next-day delivery available.
Need to work out your dose?
Use our reconstitution calculator β syringe units in seconds.
Research Use Only β Disclaimer
This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.
Don't have supplies? Grab them while you're here.
